CXCL8 and rheumatic heart disease: Similarly, our study demonstrated that DEX significantly lowered myocardial injury markers (cTnI and CK-MB) and inflammatory markers (IL-8, TNF-α), increasing IL-10 levels in patients undergoing valve replacement for rheumatic heart disease.